Applicant, as named in the Orange Book
Rosemont Pharms
Next listed expiry: Atmeksi on 9 Oct 2044. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Atmeksi NDA 219843 methocarbamol | 9 Oct 2044 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.